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Background:  Presence of late gadolinium enhancement (LGE) on cardiac MRI (CMR) in non-ischemic cardiomyopathy (NICM) may predict 
adverse cardiac events. Current published studies are limited by sample size and varying outcomes. We sought to better evaluate the utility of LGE in 
NICM with a meta-analysis.
Methods:  A systemic review of PUBMED, and MEDLINE (1995 to date) was performed for all trials assessing prognostic value of LGE in NICM. 
Studies included specified cardiac outcomes: cardiac death, sudden cardiac death, ICD therapy, sustained ventricular arrhythmia, heart failure 
hospitalization and transplantation. A mixed effect generalized linear model was used to evaluate the proportion of adverse events in each group in 
each study.
Results:  Four studies, all prospective observational, comprising 475 patients (Weighted Mean Age 54 +/- 11 yrs, 141 (30%) male) fulfilled the 
inclusion criteria. LVEF ranged from 21 - 42% in the LGE+ group and 26 - 50% in the LGE- group. There were a total of 85 events of which 62 (73%) 
occurred in the LGE+ group. Compared to patients without LGE, the odds of having an adverse cardiac event for those with LGE was 3.56 times 
higher (95% CI (1.32, 9.61); p-value=0.024). Covariates such as age and LVEF were not significant in predicting adverse events.
Conclusions:  These results show that the presence of LGE is a strong independent predictor of adverse cardiac outcomes. Further studies are 
needed to better risk stratify those who need closer outpatient follow up and/or ICD implantation.
